ResMed (RMD) Revenue & Revenue Breakdown
ResMed Revenue Highlights
Latest Revenue (Y)
$4.69B
Latest Revenue (Q)
$1.20B
Main Segment (Y)
Sleep And Respiratory
Main Geography (Y)
UNITED STATES
ResMed Revenue by Period
ResMed Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $4.69B | 10.95% |
| 2023-06-30 | $4.22B | 18.02% |
| 2022-06-30 | $3.58B | 11.93% |
| 2021-06-30 | $3.20B | 8.11% |
| 2020-06-30 | $2.96B | 13.44% |
| 2019-06-30 | $2.61B | 11.38% |
| 2018-06-30 | $2.34B | 13.23% |
| 2017-06-30 | $2.07B | 12.40% |
| 2016-06-30 | $1.84B | 9.52% |
| 2015-06-30 | $1.68B | 7.97% |
| 2014-06-30 | $1.55B | 2.68% |
| 2013-06-30 | $1.51B | 10.66% |
| 2012-06-30 | $1.37B | 10.08% |
| 2011-06-30 | $1.24B | 13.80% |
| 2010-06-30 | $1.09B | 18.64% |
| 2009-06-30 | $920.74M | 10.22% |
| 2008-06-30 | $835.40M | 16.62% |
| 2007-06-30 | $716.33M | 18.01% |
| 2006-06-30 | $607.00M | 42.65% |
| 2005-06-30 | $425.50M | 25.39% |
| 2004-06-30 | $339.34M | 24.04% |
| 2003-06-30 | $273.57M | 34.05% |
| 2002-06-30 | $204.08M | 31.53% |
| 2001-06-30 | $155.16M | 34.20% |
| 2000-06-30 | $115.61M | 30.49% |
| 1999-06-30 | $88.60M | 33.23% |
| 1998-06-30 | $66.50M | 35.16% |
| 1997-06-30 | $49.20M | 42.20% |
| 1996-06-30 | $34.60M | 47.23% |
| 1995-06-30 | $23.50M | 69.06% |
| 1994-06-30 | $13.90M | 80.52% |
| 1993-06-30 | $7.70M | - |
ResMed generated $4.69B in revenue during NA 2024, up 10.95% compared to the previous quarter, and up 179.75% compared to the same period a year ago.
ResMed Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $1.20B | 2.94% |
| 2023-12-31 | $1.16B | 20.74% |
| 2023-09-30 | $963.04M | -14.17% |
| 2023-06-30 | $1.12B | 0.46% |
| 2023-03-31 | $1.12B | 8.04% |
| 2022-12-31 | $1.03B | 8.78% |
| 2022-09-30 | $950.29M | 3.89% |
| 2022-06-30 | $914.74M | 5.81% |
| 2022-03-31 | $864.50M | -3.39% |
| 2021-12-31 | $894.87M | -1.01% |
| 2021-09-30 | $904.01M | 3.19% |
| 2021-06-30 | $876.10M | 13.96% |
| 2021-03-31 | $768.77M | -3.91% |
| 2020-12-31 | $800.01M | 6.39% |
| 2020-09-30 | $751.94M | -2.39% |
| 2020-06-30 | $770.34M | 0.12% |
| 2020-03-31 | $769.46M | 4.52% |
| 2019-12-31 | $736.16M | 8.09% |
| 2019-09-30 | $681.06M | -3.39% |
| 2019-06-30 | $704.96M | 6.45% |
| 2019-03-31 | $662.23M | 1.71% |
| 2018-12-31 | $651.10M | 10.68% |
| 2018-09-30 | $588.28M | -5.67% |
| 2018-06-30 | $623.63M | 5.41% |
| 2018-03-31 | $591.63M | -1.60% |
| 2017-12-31 | $601.27M | 14.82% |
| 2017-09-30 | $523.66M | -5.93% |
| 2017-06-30 | $556.69M | 8.26% |
| 2017-03-31 | $514.20M | -3.05% |
| 2016-12-31 | $530.40M | 13.95% |
| 2016-09-30 | $465.45M | -10.26% |
| 2016-06-30 | $518.65M | 14.27% |
| 2016-03-31 | $453.88M | -0.15% |
| 2015-12-31 | $454.54M | 10.42% |
| 2015-09-30 | $411.65M | -9.14% |
| 2015-06-30 | $453.06M | 7.23% |
| 2015-03-31 | $422.50M | -0.11% |
| 2014-12-31 | $422.95M | 11.19% |
| 2014-09-30 | $380.40M | -8.38% |
| 2014-06-30 | $415.21M | 4.39% |
| 2014-03-31 | $397.76M | 3.49% |
| 2013-12-31 | $384.34M | 7.46% |
| 2013-09-30 | $357.66M | -13.73% |
| 2013-06-30 | $414.61M | 8.09% |
| 2013-03-31 | $383.58M | 1.87% |
| 2012-12-31 | $376.54M | 10.83% |
| 2012-09-30 | $339.73M | -8.66% |
| 2012-06-30 | $371.93M | 6.55% |
| 2012-03-31 | $349.07M | 4.91% |
| 2011-12-31 | $332.74M | 5.71% |
| 2011-09-30 | $314.77M | -7.93% |
| 2011-06-30 | $341.89M | 9.14% |
| 2011-03-31 | $313.26M | 2.38% |
| 2010-12-31 | $305.99M | 8.50% |
| 2010-09-30 | $282.01M | -3.28% |
| 2010-06-30 | $291.57M | 4.63% |
| 2010-03-31 | $278.66M | 1.28% |
| 2009-12-31 | $275.13M | 11.39% |
| 2009-09-30 | $246.99M | -1.97% |
| 2009-06-30 | $251.96M | 10.57% |
| 2009-03-31 | $227.87M | 2.19% |
| 2008-12-31 | $222.98M | 2.32% |
| 2008-09-30 | $217.93M | -7.32% |
| 2008-06-30 | $235.15M | 11.01% |
| 2008-03-31 | $211.83M | - |
ResMed generated $1.20B in revenue during Q3 2024, up 2.94% compared to the previous quarter, and up 115.79% compared to the same period a year ago.
ResMed Revenue Breakdown
ResMed Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Jun 23 | Jun 22 | Jun 21 | Jun 20 | Jun 19 |
|---|---|---|---|---|---|
| Software As A Service | $497.98M | - | - | - | - |
| Software As Service | $497.98M | $400.83M | $373.59M | $354.63M | $275.80M |
| Sleep And Respiratory | $3.73B | $3.18B | $2.82B | $2.60B | - |
| Devices | - | - | - | - | $743.10M |
| Devices And Masks | - | - | - | - | $910.30M |
| Masks | - | - | - | - | $677.40M |
ResMed's latest annual revenue breakdown by segment (product or service), as of Jun 23: Sleep And Respiratory (78.90%), Software As A Service (10.55%), and Software As Service (10.55%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Software As Service | $147.96M | $144.95M | $139.28M | $136.78M | $116.76M | $105.85M | $101.14M | $99.03M | $97.52M | $95.78M | $91.48M | $89.56M | $86.71M | $86.90M | $85.20M | $79.90M | - | - | - | - |
| Sleep And Respiratory | $1.05B | $1.02B | $963.04M | $983.48M | $980.12M | $916.98M | $844.44M | $763.36M | $795.84M | $806.50M | $780.33M | $674.93M | $708.18M | $659.80M | - | - | - | - | - | - |
| Devices And Masks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $678.87M | $679.89M | $649.45M | $594.20M | $619.80M | $582.30M |
| Software As Service Before Deferred Revenue Adjustment | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $91.48M | $89.56M | $87.36M | $88.30M | $86.20M | $82.20M |
| Masks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $245.80M |
| Devices | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $336.50M |
ResMed's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Sleep And Respiratory (87.64%), and Software As Service (12.36%).
ResMed Revenue Breakdown by Country
Annual Revenue by Country
| Country | Jun 23 | Jun 22 | Jun 21 | Jun 20 | Jun 19 |
|---|---|---|---|---|---|
| UNITED STATES | $2.72B | - | - | - | - |
| Global | $1.50B | $3.58B | $3.20B | $2.96B | $2.61B |
| U [S] | $2.72B | - | - | - | - |
| Rest Of World | $1.50B | - | - | - | - |
| U.s. Canada And Latin America | - | $2.38B | $2.08B | $1.93B | $1.70B |
ResMed's latest annual revenue breakdown by geography, as of Jun 23: UNITED STATES (32.20%), U [S] (32.20%), Global (17.80%), and Rest Of World (17.80%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Jun 19 | Mar 19 | Dec 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Combined Europe Asia And Other Markets | $361.55M | $348.52M | $324.68M | $115.16M | $104.45M | $266.34M | $287.93M | $309.03M | $315.46M | $99.21M | $93.42M | $80.62M | $91.31M | $77.10M | $73.20M | - | - | - | - | - |
| Global | $1.20B | $1.16B | $1.10B | $1.12B | $136.78M | $116.76M | $105.85M | $914.74M | $101.14M | $99.03M | $97.52M | $876.10M | $93.84M | $91.83M | $92.14M | $770.34M | $89.56M | $705.00M | $79.90M | $63.20M |
| Us Canada And Latin America | $687.47M | $669.33M | $638.36M | $257.07M | $269.73M | $105.85M | $101.14M | $99.03M | $97.52M | $93.84M | $91.83M | $92.14M | $89.56M | $79.90M | $63.20M | - | - | - | - | - |
ResMed's latest quarterly revenue breakdown by geography, as of Mar 24: Global (53.29%), Us Canada And Latin America (30.61%), and Combined Europe Asia And Other Markets (16.10%).
ResMed Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BDX | Becton, Dickinson and Company | $19.37B | $4.99B |
| BAX | Baxter | $14.81B | $3.59B |
| ALC | Alcon | $10.09B | $2.46B |
| RMD | ResMed | $4.69B | $1.20B |
| HOLX | Hologic | $4.03B | $1.01B |
| COO | Cooper Companies | $3.59B | $1.00B |
| TFX | Teleflex | $2.97B | $749.69M |
| WST | West Pharmaceutical Services | $2.95B | $702.00M |
| ICUI | ICU Medical | $2.26B | $596.46M |
| MMSI | Merit Medical Systems | $1.26B | $338.00M |
| EMBC | Embecta | $1.12B | $272.50M |
| STAA | STAAR Surgical Company | $322.42K | $77.36M |
RMD Revenue FAQ
What is ResMed’s yearly revenue?
ResMed's yearly revenue for 2024 was $4.69B, representing an increase of 10.95% compared to 2023. The company's yearly revenue for 2023 was $4.22B, representing an increase of 18.02% compared to 2022. RMD's yearly revenue for 2022 was $3.58B, representing an increase of 11.93% compared to 2021.
What is ResMed’s quarterly revenue?
ResMed's quarterly revenue for Q3 2024 was $1.2B, a 2.94% increase from the previous quarter (Q2 2024), and a 7.17% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.16B, a 20.74% increase from the previous quarter (Q1 2024), and a 12.48% increase year-over-year (Q2 2023). RMD's quarterly revenue for Q1 2024 was $963.04M, a -14.17% decrease from the previous quarter (Q4 2023), and a 1.34% increase year-over-year (Q1 2023).
What is ResMed’s revenue growth rate?
ResMed's revenue growth rate for the last 3 years (2022-2024) was 30.94%, and for the last 5 years (2020-2024) was 58.45%.
What are ResMed’s revenue streams?
ResMed's revenue streams in n 23 are Software As A Service, Software As Service, and Sleep And Respiratory. Software As A Service generated $497.98M in revenue, accounting 10.55% of the company's total revenue Software As Service generated $497.98M in revenue, accounting 10.55% of the company's total revenue, up 24.24% year-over-year. Sleep And Respiratory generated $3.73B in revenue, accounting 78.90% of the company's total revenue, up 17.24% year-over-year.
What is ResMed’s main source of revenue?
For the fiscal year ending Jun 23, the largest source of revenue of ResMed was Sleep And Respiratory. This segment made a revenue of $3.73B, representing 78.90% of the company's total revenue.